BreezeBio

BreezeBioBreezeBio
BreezeBio

BreezeBio

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Website
DR 02016Active63Alameda, US
Rate
Advertise here

About

BreezeBio, formerly GenEdit, is a biotechnology company focused on developing genetic medicines through targeted in vivo delivery. It utilizes its proprietary NanoGalaxy® platform, which consists of non-viral, non-lipid hydrophilic nanoparticles (HNPs). These nanoparticles are engineered to deliver various genetic payloads, including mRNA, siRNA, and gene editors, to specific cell types and tissues, such as immune cells, heart, lung, and central nervous system. The company is advancing an internal therapeutic pipeline with an initial focus on autoimmune diseases and oncology, with its lead candidate, BRZ-101, designed to restore immune tolerance in Type 1 diabetes. BreezeBio also engages in partnered programs to leverage its delivery technology.
Frequently asked

What does BreezeBio do?

BreezeBio, formerly GenEdit, is a biotechnology company focused on developing genetic medicines through targeted in vivo delivery. It utilizes its proprietary NanoGalaxy® platform, which consists of non-viral, non-lipid hydrophilic nanoparticles (HNPs). These nanoparticles are engineered to deliver various genetic payloads, including mRNA, siRNA, and gene editors, to specific cell types and tissues, such as immune cells, heart, lung, and central nervous system. The company is advancing an intern…

What is BreezeBio's revenue?

StartupHub estimates BreezeBio's annual revenue at $6.8M (range $4.1M to $24.1M, 69% confidence), based on comparable companies in the sector.

What is BreezeBio's valuation?

StartupHub estimates BreezeBio's effective valuation at $35.7M (range $20.8M to $69.6M, 56% confidence), based on comparable companies in the sector.

How much funding has BreezeBio raised?

BreezeBio has raised a total of $94M in funding. The most recent round on record is Series B.

Where is BreezeBio headquartered?

BreezeBio is headquartered in Alameda, California, US.

When was BreezeBio founded?

BreezeBio was founded in 2016.

What industry does BreezeBio operate in?

BreezeBio operates in Biotechnology, Genetic Medicine, Therapeutics, Drug Discovery.

How many employees does BreezeBio have?

BreezeBio has approximately 63 people on record.

HEADCOUNT
63
DOMAIN RATING
0
New entrants in Biotechnology
Last 90 days
7
New entrants
2.3
Per month
0.5
Per week
Most recent
Galatek

Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.

Jul 13
Raven4batchrecords

Digital batch record software for pharmaceutical and biotech manufacturing.

Jul 9
Trofinetide

Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.

Jun 8
Nanorobotics

A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.

May 28
Matrixcode

MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.

May 27
Cypherpunkcode

A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.

May 26

An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.